Chemed Co. (NYSE:CHE) Shares Sold by Man Group plc

Man Group plc reduced its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 6.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,667 shares of the company's stock after selling 2,111 shares during the period. Man Group plc owned 0.20% of Chemed worth $16,247,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in CHE. Nomura Holdings Inc. acquired a new position in shares of Chemed during the 4th quarter valued at about $1,053,000. Nuveen Asset Management LLC raised its stake in Chemed by 18.0% during the fourth quarter. Nuveen Asset Management LLC now owns 39,451 shares of the company's stock worth $20,901,000 after purchasing an additional 6,005 shares during the period. Occudo Quantitative Strategies LP boosted its holdings in Chemed by 214.1% in the 4th quarter. Occudo Quantitative Strategies LP now owns 1,652 shares of the company's stock valued at $875,000 after purchasing an additional 1,126 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Chemed by 16.8% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,358 shares of the company's stock valued at $1,779,000 after purchasing an additional 482 shares during the last quarter. Finally, Lazard Asset Management LLC grew its stake in shares of Chemed by 245.4% in the 4th quarter. Lazard Asset Management LLC now owns 10,166 shares of the company's stock valued at $5,385,000 after buying an additional 7,223 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CHE. Wall Street Zen raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada raised their target price on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th.

Insider Buying and Selling at Chemed

In related news, EVP Spencer S. Lee sold 1,500 shares of the firm's stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $577.99, for a total transaction of $866,985.00. Following the completion of the transaction, the executive vice president now directly owns 14,627 shares in the company, valued at $8,454,259.73. This trade represents a 9.30% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This represents a 1.91% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,500 shares of company stock valued at $4,401,120 over the last quarter. 3.29% of the stock is owned by company insiders.

Chemed Trading Up 0.4%

CHE traded up $2.04 on Friday, hitting $563.48. The company had a trading volume of 18,985 shares, compared to its average volume of 102,272. The firm has a market cap of $8.24 billion, a P/E ratio of 28.48, a PEG ratio of 2.15 and a beta of 0.59. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $623.61. The company's fifty day moving average price is $584.33 and its 200 day moving average price is $565.10.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business's revenue for the quarter was up 9.8% on a year-over-year basis. During the same period last year, the business earned $5.20 earnings per share. On average, analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed's payout ratio is 9.74%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.